<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00510000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P68400</UniProt_ID>
  <Seq_Length>391</Seq_Length>
  <Molecule_Weight>45144</Molecule_Weight>
  <KEGG_ID>hsa:1457</KEGG_ID>
  <Orthology_ID>K03097</Orthology_ID>
  <EBI_ID>EBI-347804</EBI_ID>
  <Function_Summary>Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apopotosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV.</Function_Summary>
  <Catalytic_Mechanism>ATP + a protein = ADP + a phosphoprotein.</Catalytic_Mechanism>
  <Pfam_ID>PF00069:Pkinase</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>5</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Casein kinase 2</Alias>
      <Alias>Casein kinase II subunit alpha</Alias>
      <Alias>Protein kinase CK2</Alias>
      <Alias>The Ser/Thr kinase CK2</Alias>
      <Alias>CK II alpha</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.</Detail>
      <Keyword>Protein N-terminus binding</Keyword>
      <Ontology_ID>GO:0047485</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.</Detail>
      <Keyword>Protein serine/threonine kinase activity</Keyword>
      <Ontology_ID>GO:0004674</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with Hsp90 proteins, any of a group of heat shock proteins around 90kDa in size.</Detail>
      <Keyword>Hsp90 protein binding</Keyword>
      <Ontology_ID>GO:0051879</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Regulation of transcription</Keyword>
      <Ontology_ID>GO:0045449</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Transcription</Keyword>
      <Ontology_ID>GO:0006350</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of Wnt receptor signaling pathway activity.</Detail>
      <Keyword>Positive regulation of Wnt receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0030177</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.</Detail>
      <Keyword>Cell cycle</Keyword>
      <Ontology_ID>GO:0007049</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of inhibiting aggregation and assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that is dependent on interaction with a chaperone.</Detail>
      <Keyword>Chaperone-mediated protein folding</Keyword>
      <Ontology_ID>GO:0061077</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of RNA on a template of DNA.</Detail>
      <Keyword>Transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006351</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.</Detail>
      <Keyword>Axon guidance</Keyword>
      <Ontology_ID>GO:0007411</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cell cycle checkpoint that delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and oriented, and chromosomes are attached to the spindle.</Detail>
      <Keyword>Mitotic cell cycle spindle checkpoint</Keyword>
      <Ontology_ID>GO:0071174</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of cellular DNA-dependent transcription.</Detail>
      <Keyword>Regulation of transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006355</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of caspase activity.</Detail>
      <Keyword>Negative regulation of caspase activity</Keyword>
      <Ontology_ID>GO:0043154</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.</Detail>
      <Keyword>Wnt receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0016055</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>277</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>102</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>194</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>7</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>127</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>50</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>362</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>287</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>125</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>344</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>255</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>360</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>370</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQ</Protein_Seq>
    <DNA_Seq>GAGCAGAGGGGAGACGGCCGCCGCCCTGGCCGCTTCCACCACAGTTTGAAGAAAACAGGTCTGAAACAAGGTCTTACCCCCAGCTGCTTCTGAACACAGTGACTGCCAGATCTCCAAACATCAAGTCCAGCTTTGTCCGCCAACCTGTCTGACATGTCGGGACCCGTGCCAAGCAGGGCCAGAGTTTACACAGATGTTAATACACACAGACCTCGAGAATACTGGGATTACGAGTCACATGTGGTGGAATGGGGAAATCAAGATGACTACCAGCTGGTTCGAAAATTAGGCCGAGGTAAATACAGTGAAGTATTTGAAGCCATCAACATCACAAATAATGAAAAAGTTGTTGTTAAAATTCTCAAGCCAGTAAAAAAGAAGAAAATTAAGCGTGAAATAAAGATTTTGGAGAATTTGAGAGGAGGTCCCAACATCATCACACTGGCAGACATTGTAAAAGACCCTGTGTCACGAACCCCCGCCTTGGTTTTTGAACACGTAAACAACACAGACTTCAAGCAATTGTACCAGACGTTAACAGACTATGATATTCGATTTTACATGTATGAGATTCTGAAGGCCCTGGATTATTGTCACAGCATGGGAATTATGCACAGAGATGTCAAGCCCCATAATGTCATGATTGATCATGAGCACAGAAAGCTACGACTAATAGACTGGGGTTTGGCTGAGTTTTATCATCCTGGCCAAGAATATAATGTCCGAGTTGCTTCCCGATACTTCAAAGGTCCTGAGCTACTTGTAGACTATCAGATGTACGATTATAGTTTGGATATGTGGAGTTTGGGTTGTATGCTGGCAAGTATGATCTTTCGGAAGGAGCCATTTTTCCATGGACATGACAATTATGATCAGTTGGTGAGGATAGCCAAGGTTCTGGGGACAGAAGATTTATATGACTATATTGACAAATACAACATTGAATTAGATCCACGTTTCAATGATATCTTGGGCAGACACTCTCGAAAGCGATGGGAACGCTTTGTCCACAGTGAAAATCAGCACCTTGTCAGCCCTGAGGCCTTGGATTTCCTGGACAAACTGCTGCGATATGACCACCAGTCACGGCTTACTGCAAGAGAGGCAATGGAGCACCCCTATTTCTACACTGTTGTGAAGGACCAGGCTCGAATGGGTTCATCTAGCATGCCAGGGGGCAGTACGCCCGTCAGCAGCGCCAATATGATGTCAGGGATTTCTTCAGTGCCAACCCCTTCACCCCTTGGACCTCTGGCAGGCTCACCAGTGATTGCTGCTGCCAACCCCCTTGGGATGCCTGTTCCAGCTGCCGCTGGCGCTCAGCAGTAACGGCCCTATCTGTCTCCTGATGCCTGAGCAGAGGTGGGGGAGTCCACCCTCTCCTTGATGCAGCTTGCGCCTGGCGGGGAGGGGTGAAACACTTCAGAAGCACCGTGTCTGAACCGTTGCTTGTGGATTTATAGTAGTTCAGTCATAAAAAAAAAAATTATAATAGGCTGATTTTCTTTTTTCTTTTTTTTTTAACTCGAACTTTTCATAACTCAGGGGATTCCCTGAAAAATTACCTGCAGGTGGAATATTTCATGGACAATTTTTTTTTCTCCCCTCCCAAATTTAGTTCCTCATCACAAAAGAACAAAGATAAACCAGCCTCAATCCCGGCTGCTGCATTTAGGTGGAGACTTCTTCCCATTCCCACCATTGTTCCTCCACCGTCCCACACTTTAGGGGGTTGGTATCTCGTGCTCTTCTCCAGAGATTACAAAAATGTAGCTTCTCAGGGGAGGCAGGAAGAAAGGAAGGAAGGAAAGAAGGAAGGGAGGACCCAATCTATAGGAGCAGTGGACTGCTTGCTGGTCGCTTACATCACTTTACTCCATAAGCGCTTCAGTGGGGTTATCCTAGTGGCTCTTGTGGAAGTGTGTCTTAGTTACATCAAGATGTTAAAATCTACCCAAAATGCAGACAGATACTAAAACTCTGTCAGTAGATCATGTCTTACTGATCTAACCCTAAATCCAACTCATTTATACTTTTATTTTTAGTTCAGTTTAAAATGTTGATACCTTCCCTCCCAGGCTCCTTACCTTGGTCTTTTCCCTGTTCATCTCCCAACATGCTGTGCTCCATAGCTGGTAGGAGAGGGAAGGCAAAATCTTTCTTAGTTTTCTTTATCTT</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CSNK2A1</Gene_Name>
    <Gene_Alias>CK2A1</Gene_Alias>
    <Gene_ID>1457</Gene_ID>
    <Genbank_ACCN>NM_001895</Genbank_ACCN>
    <Protein_ACCN>NP_001886</Protein_ACCN>
    <HGNC_ID>2457</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1457</Gene_URL>
    <UCSC_ID>uc002wdw.1</UCSC_ID>
    <EMBL_ID>ENSG00000101266</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P19784</Uniprot_ID>
      <Gene_Name>CSNK2A2</Gene_Name>
      <EBI_ID>EBI-347451</EBI_ID>
      <PPI_EBI_URL>EBI-347804,EBI-347451</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O00257-3</Uniprot_ID>
      <Gene_Name>CBX4</Gene_Name>
      <EBI_ID>EBI-4392727</EBI_ID>
      <PPI_EBI_URL>EBI-347804,EBI-4392727</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O60282</Uniprot_ID>
      <Gene_Name>KIF5C</Gene_Name>
      <EBI_ID>EBI-717170</EBI_ID>
      <PPI_EBI_URL>EBI-347804,EBI-717170</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q96EB6</Uniprot_ID>
      <Gene_Name>SIRT1</Gene_Name>
      <EBI_ID>EBI-1802965</EBI_ID>
      <PPI_EBI_URL>EBI-347804,EBI-1802965</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P29590</Uniprot_ID>
      <Gene_Name>PML</Gene_Name>
      <EBI_ID>EBI-295890</EBI_ID>
      <PPI_EBI_URL>EBI-347804,EBI-295890</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P67870</Uniprot_ID>
      <Gene_Name>CSNK2B</Gene_Name>
      <EBI_ID>EBI-348169</EBI_ID>
      <PPI_EBI_URL>EBI-347804,EBI-348169</PPI_EBI_URL>
      <Experiment_Number>10</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Globozoospermia</Disease_Name>
      <Disease_Detail>Globozoospermia</Disease_Detail>
      <Disease_DB>GLB004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/globozoospermia?search=CSNK2A1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Human CK2 catalytic domain in complex with a difurane derivative inhibitor (CPA)</PDB_Title>
      <PDB_ID>3MB6</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MB6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.</PubMed_Title>
      <Author>Lopez-Ramos M, et al.</Author>
      <Journal>FASEB J. 2010 May 3.</Journal>
      <PubMed_ID>20400536</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human CK2 catalytic domain in complex with a difurane derivative inhibitor (AMR)</PDB_Title>
      <PDB_ID>3MB7</PDB_ID>
      <Resolution>1.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MB7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.</PubMed_Title>
      <Author>Lopez-Ramos M, et al.</Author>
      <Journal>FASEB J. 2010 May 3.</Journal>
      <PubMed_ID>20400536</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Protein Kinase CK2 Holoenzyme</PDB_Title>
      <PDB_ID>1JWH</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1JWH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme.</PubMed_Title>
      <Author>Niefind K, et al.</Author>
      <Journal>EMBO J. 2001 Oct 1;20(19):5320-31.</Journal>
      <PubMed_ID>11574463</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Inactive conformation of human protein kinase CK2 catalytic subunit</PDB_Title>
      <PDB_ID>3FWQ</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FWQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>First Inactive Conformation of CK2alpha, the Catalytic Subunit of Protein Kinase CK2</PubMed_Title>
      <Author>Raaf J, et al.</Author>
      <Journal>(2009) J.Mol.Biol.  386: 1212-1221</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the catalytic subunit of protein kinase CK2 (C-terminal deletion mutant 1-335) in complex with two sulfate ions</PDB_Title>
      <PDB_ID>2PVR</PDB_ID>
      <Resolution>1.61</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PVR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Evolved to be active: sulfate ions define substrate recognition sites of CK2alpha and emphasise its exceptional role within the CMGC family of eukaryotic protein kinases.</PubMed_Title>
      <Author>Niefind K, et al.</Author>
      <Journal>J Mol Biol. 2007 Jul 13;370(3):427-38.</Journal>
      <PubMed_ID>17524418</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>High pH-value crystal structure of emodin in complex with the catalytic subunit of protein kinase CK2</PDB_Title>
      <PDB_ID>3BQC</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3BQC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.</PubMed_Title>
      <Author>Raaf J, et al.</Author>
      <Journal>J Mol Biol. 2008 Mar 14;377(1):1-8.</Journal>
      <PubMed_ID>18242640</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the catalytic subunit of human protein kinase CK2 with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole</PDB_Title>
      <PDB_ID>3H30</PDB_ID>
      <Resolution>1.56</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3H30</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00510001</ASD_Ligand>
      <PubMed_Title>The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.</PubMed_Title>
      <Author>Raaf J, et al.</Author>
      <Journal>Chem Biol. 2008 Feb;15(2):111-7.</Journal>
      <PubMed_ID>18291315</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human CK2 alpha complexed with Ellagic acid</PDB_Title>
      <PDB_ID>2ZJW</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ZJW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.</PubMed_Title>
      <Author>Sekiguchin Y, et al.</Author>
      <Journal>Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3.</Journal>
      <PubMed_ID>19414254</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of a mutant of human protein kinase CK2alpha with altered cosubstrate specificity</PDB_Title>
      <PDB_ID>3JUH</PDB_ID>
      <Resolution>1.66</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3JUH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.</PubMed_Title>
      <Author>Raaf J, et al.</Author>
      <Journal>Chem Biol. 2008 Feb;15(2):111-7.</Journal>
      <PubMed_ID>18291315</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit</PDB_Title>
      <PDB_ID>1PJK</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PJK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.</PubMed_Title>
      <Author>Ermakova I, et al.</Author>
      <Journal>J Mol Biol. 2003 Jul 25;330(5):925-34.</Journal>
      <PubMed_ID>12860116</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the catalytic subunit of human protein kinase CK2</PDB_Title>
      <PDB_ID>1NA7</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NA7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2.</PubMed_Title>
      <Author>Pechkova E, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr. 2003 Dec;59(Pt 12):2133-9.</Journal>
      <PubMed_ID>14646071</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Low pH-value crystal structure of emodin in complex with the catalytic subunit of protein kinase CK2</PDB_Title>
      <PDB_ID>3C13</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3C13</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.</PubMed_Title>
      <Author>Raaf J, et al.</Author>
      <Journal>J Mol Biol. 2008 Mar 14;377(1):1-8.</Journal>
      <PubMed_ID>18242640</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04712</Pathway_ID>
      <Pathway_Title>Circadian rhythm - plant</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05169</Pathway_ID>
      <Pathway_Title>Epstein-Barr virus infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04530</Pathway_ID>
      <Pathway_Title>Tight junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05162</Pathway_ID>
      <Pathway_Title>Measles</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04520</Pathway_ID>
      <Pathway_Title>Adherens junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04310</Pathway_ID>
      <Pathway_Title>Wnt signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04712</Pathway_ID>
      <Pathway_Title>Circadian rhythm - plant</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.daa.b.b.be.html</SCOP_URL>
    <CATH_Class>Mainly alpha@@Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/3fwq@@http://www.cathdb.info/pdb/3fwq</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,41,Leu;site,67,Val;site,112,Val;site,101,Val;site,39,Tyr;range,104,105,beta4-beta5-loop</Site_Detail>
      <Site_Reference>Raaf J, et al. Chem Biol. 2008,15(2):111-117.</Site_Reference>
      <Site_Type>Open-Close</Site_Type>
      <PDB_ID>3H30</PDB_ID>
      <PubMed_ID>18291315</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.11.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/11/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00510001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00510002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00510003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00510004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00510005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>